CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common stock:	Additional paid-in-capital:	Treasury stock at cost:	Retained earnings:	Accumulated other comprehensive income:
Beginning balance at Dec. 31, 2021		$ 2	$ 16,659	$ (43,371)	$ 36,090	$ 398
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		0
Common stock repurchased		0
Common stock and stock-based awards issued			1
Tax withholdings related to net share settlements of restricted stock units and awards			(61)
Stock-based compensation			111
Common stock repurchased			188	(1,438)
Other			6
Net income (loss)	$ (1,341)				(1,341)
Dividends and dividend equivalents declared					(134)
Foreign currency translation adjustment						(34)
Change in unrealized gains (losses) on investments	(51)					(51)
Change in unrealized gains (losses) on derivative instruments						20
Tax benefit (provision) on above items						9
Ending balance at Mar. 31, 2022	$ 7,054	2	16,904	(44,809)	34,615	342
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 0.22
Beginning balance at Dec. 31, 2022	$ 5,153	2	17,279	(46,702)	34,315	259
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		0
Common stock repurchased		0
Common stock and stock-based awards issued			0
Tax withholdings related to net share settlements of restricted stock units and awards			(48)
Stock-based compensation			128
Common stock repurchased	(250)		0	(252)
Other			5
Net income (loss)	567				567
Dividends and dividend equivalents declared					(138)
Foreign currency translation adjustment						1
Change in unrealized gains (losses) on investments	19					19
Change in unrealized gains (losses) on derivative instruments						(53)
Tax benefit (provision) on above items						5
Ending balance at Mar. 31, 2023	$ 5,387	$ 2	$ 17,364	$ (46,954)	$ 34,744	$ 231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 0.25